Xuling Sun

423 citations
8 papers · 277 indexed · h-index 7
Topics
PI3K/AKT/mTOR signaling in cancer (3 papers)Cytokine Signaling Pathways and Interactions (2 papers)interferon and immune responses (1 paper)
Journals
SHILAP Revista de lepidopterologíaExperimental Cell ResearchMolecular Cancer
Partner nations
China

In The Last Decade

Xuling Sun

7 papers receiving 276 citations

Peers

Xuling Sun
Comparison fields: 5 of 62
  • Molecular Biology 178
  • Cancer Research 85
  • Oncology 60
  • Geriatrics and Gerontology 32
  • Epidemiology 32
Replace Daniel Sasca with:
Daniel Sasca Germany
Xiangqiong Mo China
Dora Ling Australia
Weiyuan Wei China
Xianghong Yang China
Xuanfu Xu China
Kyle M. LaPak United States
Inès J. Goossens-Beumer Netherlands
Peifen Fu China
Maopeng Yang China
Xuling Sun relative to Daniel Sasca Germany Daniel Sasca's profile →
Citations per field
00.5×1.5×
Daniel Sasca · 1×
Citations per year

Countries citing papers authored by Xuling Sun

Since Specialization
Citations

This map shows the geographic impact of Xuling Sun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xuling Sun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xuling Sun more than expected).

Fields of papers citing papers by Xuling Sun

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xuling Sun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xuling Sun. The network helps show where Xuling Sun may publish in the future.

Co-authorship network of co-authors of Xuling Sun

This figure shows the co-authorship network connecting the top 25 collaborators of Xuling Sun. A scholar is included among the top collaborators of Xuling Sun based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xuling Sun. Xuling Sun is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
#WorkIndexed citations
1 0
2
EZH2-triggered methylation of SMAD3 promotes its activation and tumor metastasis
31
3 11
4 40
5
SIX4 promotes metastasis through STAT3 activation in breast cancer.
25
6 22
7 68
8 80

About Xuling Sun

Xuling Sun is a scholar working on Geriatrics and Gerontology, Biophysics and Cancer Research, having authored 8 papers that have together received 277 indexed citations. Recurring topics across this work include PI3K/AKT/mTOR signaling in cancer (3 papers), Cytokine Signaling Pathways and Interactions (2 papers) and interferon and immune responses (1 paper). The work is most often cited by research in Geriatrics and Gerontology (32 citations), Cancer Research (85 citations) and Molecular Biology (178 citations). Xuling Sun has collaborated with scholars based in China. Frequent co-authors include Junbo Hu, Xuelai Luo, Guihua Wang, Fuqing Hu, Zhenlin Hou, Qi Wu, Yaqi Chen, Yongdong Feng, Xi Yang and Geng Li. Their work appears in journals such as SHILAP Revista de lepidopterología, Experimental Cell Research and Molecular Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026